Sowell Financial Services LLC Viking Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$5.19 - $6.73 $7,229 - $9,374	-1,393 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$5.74 - $9.67 $838 - $1,411	146 Added 11.71%	1,393 $8,000
Q4 2020 Jan 13, 2021	SELL	$5.3 - $6.71 $3,248 - $4,113	-613 Reduced 32.96%	1,247 $7,000
Q2 2020 Aug 13, 2020	BUY	$4.35 - $8.08 $2,501 - $4,646	575 Added 44.75%	1,860 $13,000
Q1 2020 May 12, 2020	SELL	$3.45 - $7.95 $103 - $238	-30 Reduced 2.28%	1,285 $6,000
Q4 2019 Feb 07, 2020	SELL	$6.38 - $8.73 $2,520 - $3,448	-395 Reduced 23.1%	1,315 $10,000
Q3 2019 Nov 14, 2019	BUY	$6.55 - $8.6 $11,200 - $14,706	1,710 New	1,710 $12,000

442

63.3M

6.23M

2.97M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.94B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.